Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-22-000031
Filing Date
2022-11-08
Accepted
2022-11-08 16:15:47
Documents
86
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20220930.htm   iXBRL 10-Q 1775198
2 EX-31.1 plrx-20220930xex311.htm EX-31.1 10531
3 EX-31.2 plrx-20220930xex312.htm EX-31.2 10499
4 EX-32.1 plrx-20220930xex321.htm EX-32.1 7377
  Complete submission text file 0001746473-22-000031.txt   7400089

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20220930.xsd EX-101.SCH 58747
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20220930_cal.xml EX-101.CAL 55499
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20220930_def.xml EX-101.DEF 307900
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20220930_lab.xml EX-101.LAB 624759
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20220930_pre.xml EX-101.PRE 445872
80 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20220930_htm.xml XML 1068503
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 221369091
SIC: 2834 Pharmaceutical Preparations